Ultragenyx wins FDA approval for first treatment targeting r...
Ultragenyx secured its first gene therapy approval, the FDA clearing GENGLYCOS as the first treatment designed to address underlying cause of GSDla.
Trump taps White House aide Heidi Overton to lead FDA
US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of FDA commissioner.
$31.1m ARPA-H funding for Siemens endovascular robotics
ARPA-H has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous remote endovascular robotics.
Akiram, ITM sign Lutetium-177 supply agreement
Akiram & ITM sign supply agreement for Lutetium-177 to support development of targeted antibody-radionuclide conjugate AKIR001 in solid tumours.
FDA greenlights Regeneron drug for rare bone disease
Regeneron's Pasatru will be the second FDA-approved treatment for fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
The Pharmaceutical Launch Excellence Summit
Where pharma leaders share strategies for successful drug launches.
Inizio Launches Connected Insights to Transform Global Medic...
Expanded APAC expertise, enhanced global infrastructure, and AI-enabled innovation to help life sciences organizations
9th Lab Asset & Facility Management Summit
Enabling Leaner, Smarter & More Resilient R&D Labs
The Evolution Summit Announces September 2026 Program for Cl...
Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026 at Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA.
Register Now for AAPS PharmSci 360!
Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.